Q4 2025 Management View James Rechtin, President and CEO, highlighted a "solid 2025 performance" and emphasized the company's ...

Humana reported a $796 million fourth quarter loss as the health insurer continued to grapple with high medical costs of its ...

Humana CEO Jim Rechtin acknowledged the noise around the latest Medicare Advantage rate notice and said that while the flat ...

Humana is nabbing MA members while UnitedHealthcare sheds lives. That leaves the companies neck and neck when it comes to MA enrollment, though Humana’s growth is a gamble at a time of elevated ...

For the quarter ended Dec. 31, Humana posted a GAAP net loss of $6.61 per share, compared with a loss of $5.76 per share a ...

Humana (HUM) stock drops as the company posts a lower than expected outlook for 2026 following similarly disappointing guidance issued by its rivals. Read more here.

Medicare Advantage open enrollment is available for enrollees from now through March 31. What experts say you should know ...

Humana Inc. (NYSE:HUM) is one of the noteworthy S&P 500 stocks Jim Cramer highlighted. Cramer highlighted what caused an ...

Humana President and CEO Jim Rechtin said the company is looking to expand its primary care footprint. “We also hope to soon announce a strategic acquisition in the primary care space,” Mr. Rechtin ...

Humana Inc. (NYSE:HUM) Q4 2025 Earnings Call Transcript February 11, 2026 Humana Inc. misses on earnings expectations.

The government proposed boosting payments to Medicare Advantage plans by 0.09% in 2027, below what they and their investors expected. What would it mean for enrollees?

Although hospital-owned plans are only a sliver of the Medicare Advantage market, their enrollment continues growing.